Cubist Systematic Strategies, LLC Palatin Technologies Inc Transaction History

Cubist Systematic Strategies, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$0.78 - $1.09 $22,982 - $32,116	-29,465 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$0.98 - $1.64 $28,875 - $48,322	29,465 New	29,465 $34,000
Q2 2018 Aug 14, 2018	SELL	$0.91 - $1.45 $50,137 - $79,889	-55,096 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$0.84 - $1.18 $46,280 - $65,013	55,096 New	55,096 $60,000

2.94K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $7.34M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.